Responses
Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
767 Safety and preliminary efficacy of mRNA-2752, a lipid nanoparticle encapsulating mRNAs encoding human OX40L/IL-23/IL-36γ for intratumoral (ITu) injection, and durvalumab (IV) in TNBC, HNSCC, and melanoma
Compose a Response to This Article
Other responses
No responses have been published for this article.